Cumberland Emerging Technologies, Inc. (CET), a company specialized in bringing early-stage biomedical technologies from their Mid-South research phase to the marketplace, has announced the completion of its newest expansion.
The company’s third expansion in 10 years, this latest increase in space and capacity brings CET’s current size to over 14,000 square feet—more than doubling the company. The expansion provides CET with more office and storage space as well as additional wet labs in the Life Sciences Center.
Located in downtown Nashville’s historic “Gateway to Nashville” building, the Life Sciences Center anchors an emerging high-tech corridor taking shape in Music City’s SoBro submarket. The center was fully leased prior to expansion, housing six life sciences firms. The new space is intended to allow current tenants to expand, as well as providing space and infrastructure to a number of start-up companies.
“We opened the facility in 2002 because we saw a need for wet lab space and other support services among emerging life sciences firms. Since then, we have expanded the facility three times as that demand continues to grow. This expansion is a significant milestone for CET and Nashville’s growing life sciences community,” according to Chief Executive Officer of Cumberland Pharmaceuticals and CET A.J. Kazimi.
A joint project of Vanderbilt University, Cumberland Pharmaceuticals and Launch Tennessee (previously known as the Tennessee Technology Development Corporation), CET aims to advance biomedical technologies and products conceived at academic research centers toward the commercial marketplace by providing expertise on intellectual property, regulatory, manufacturing and market issues as well as managing the development and commercialization process for select projects.
Photo courtesy of Google maps